Home
Aurobindo Pharma Ltd Share Price History
Aurobindo Pharma Ltd
NSE : 12 Feb, 2025
1144.55-3.2 (-0.3%)
Prev Close
1147.7
Open Price
1150.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
424894
Today's High / Low
1155.2 / 1120.6
52 WK High / Low
1592.0 / 958.5
Market Price of Aurobindo Pharma Ltd
1M
1Y
3Y
5Y
Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 38.88 |
| YoY Gr. | - |
| Net Profit (Cr.) | 2301 |
| BVPS | 159.96 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 27.13 |
| Op. Profit Mgn % | 21.68 |
| Net Profit Mgn % | 12.8 |
| Debt to Equity % | 0.92 |
Latest Shareholding
Promoters Holdings Over Time
About Aurobindo Pharma Ltd
- Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
- Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
- APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
- The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
- APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.
FAQs for Aurobindo Pharma Ltd Share Price History
What are the key events that typically impact Aurobindo Pharma Ltd's share price history?
Key events that impact Aurobindo Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Aurobindo Pharma Ltd's share price history?
Stock splits reduce the nominal price of Aurobindo Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Aurobindo Pharma Ltd?
Dividends can influence Aurobindo Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Aurobindo Pharma Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Aurobindo Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Aurobindo Pharma Ltd’s share price history?
To understand Aurobindo Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
